205 related articles for article (PubMed ID: 3200858)
1. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.
Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9788-91. PubMed ID: 3200858
[TBL] [Abstract][Full Text] [Related]
2. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197
[TBL] [Abstract][Full Text] [Related]
3. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens.
Bartsch H; Malaveille C; Friesen M; Kadlubar FF; Vineis P
Eur J Cancer; 1993; 29A(8):1199-207. PubMed ID: 8518034
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
5. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking.
Vineis P; Caporaso N; Tannenbaum SR; Skipper PL; Glogowski J; Bartsch H; Coda M; Talaska G; Kadlubar F
Cancer Res; 1990 May; 50(10):3002-4. PubMed ID: 2334904
[TBL] [Abstract][Full Text] [Related]
6. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
[TBL] [Abstract][Full Text] [Related]
7. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers.
Bartsch H; Caporaso N; Coda M; Kadlubar F; Malaveille C; Skipper P; Talaska G; Tannenbaum SR; Vineis P
J Natl Cancer Inst; 1990 Dec; 82(23):1826-31. PubMed ID: 2250298
[TBL] [Abstract][Full Text] [Related]
8. Molecular dosimetry of aromatic amines in human populations.
Skipper PL; Tannenbaum SR
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):17-21. PubMed ID: 7889842
[TBL] [Abstract][Full Text] [Related]
9. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero.
Coghlin J; Gann PH; Hammond SK; Skipper PL; Taghizadeh K; Paul M; Tannenbaum SR
J Natl Cancer Inst; 1991 Feb; 83(4):274-80. PubMed ID: 1994056
[TBL] [Abstract][Full Text] [Related]
10. Effects of timing and type of tobacco in cigarette-induced bladder cancer.
Vineis P; Esteve J; Hartge P; Hoover R; Silverman DT; Terracini B
Cancer Res; 1988 Jul; 48(13):3849-52. PubMed ID: 3378220
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 4-aminobiphenyl hemoglobin adducts in smokers and nonsmokers by pseudo capillary on-column gas chromatography- tandem mass spectrometry.
Seyler TH; Reyes LR; Bernert JT
J Anal Toxicol; 2010; 34(6):304-11. PubMed ID: 20663282
[TBL] [Abstract][Full Text] [Related]
12. Nonsmoking-related arylamine exposure and bladder cancer risk.
Skipper PL; Tannenbaum SR; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
[TBL] [Abstract][Full Text] [Related]
13. Molecular epidemiology of bladder cancer.
Vineis P; Martone T
Ann Ist Super Sanita; 1996; 32(1):21-7. PubMed ID: 8967722
[TBL] [Abstract][Full Text] [Related]
14. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers.
Hammond SK; Coghlin J; Gann PH; Paul M; Taghizadeh K; Skipper PL; Tannenbaum SR
J Natl Cancer Inst; 1993 Mar; 85(6):474-8. PubMed ID: 8445675
[TBL] [Abstract][Full Text] [Related]
15. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
[TBL] [Abstract][Full Text] [Related]
16. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers.
Riedel K; Scherer G; Engl J; Hagedorn HW; Tricker AR
J Anal Toxicol; 2006 Apr; 30(3):187-95. PubMed ID: 16803653
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.
Bryant MS; Skipper PL; Tannenbaum SR; Maclure M
Cancer Res; 1987 Jan; 47(2):602-8. PubMed ID: 3791245
[TBL] [Abstract][Full Text] [Related]
18. Detection of carcinogenic aromatic amines in the urine of non-smokers.
Grimmer G; Dettbarn G; Seidel A; Jacob J
Sci Total Environ; 2000 Feb; 247(1):81-90. PubMed ID: 10721145
[TBL] [Abstract][Full Text] [Related]
19. Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine.
Gaber K; Harréus UA; Matthias C; Kleinsasser NH; Richter E
Toxicology; 2007 Jan; 229(1-2):157-64. PubMed ID: 17129655
[TBL] [Abstract][Full Text] [Related]
20. Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines.
Falter B; Kutzer C; Richter E
Clin Investig; 1994 May; 72(5):364-71. PubMed ID: 8086771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
